Subtopic Deep Dive

← Health Systems, Economic Evaluations, Quality of Life

EQ-5D Utility Valuation
Research Guide

What is EQ-5D Utility Valuation?

EQ-5D Utility Valuation develops preference-based value sets for EQ-5D health states using time trade-off and discrete choice experiments for QALY calculations in economic evaluations.

EQ-5D-5L value sets, like the England set from Devlin et al. (2017, 1329 citations), use discrete choice experiments with 1000+ respondents. Studies validate these across populations (Szende, 2013, 758 citations) and map to disease-specific measures. Over 10 high-citation papers since 1998 address valuation methods and reporting standards.

Curated Papers

Key Challenges

Why It Matters

EQ-5D value sets standardize QALYs for health technology assessments by NICE and equivalents globally (Devlin et al., 2017). Devlin and Brooks (2017, 1110 citations) detail its use in cost-effectiveness analyses underpinning drug approvals. Husereau et al. (2013, 1975 citations) and Husereau et al. (2022, 747 citations) set CHEERS reporting standards ensuring valuation studies inform policy reliably.

Key Research Challenges

Population-Specific Value Sets

Value sets vary by country due to cultural differences in health preferences (Devlin et al., 2017). Time trade-off and DCE methods require large samples for representativeness (Soekhai et al., 2018). Validation across diverse populations remains inconsistent (Szende, 2013).

Discrete Choice Experiment Design

DCEs demand efficient designs to minimize respondent burden while capturing preferences accurately (Soekhai et al., 2018, 746 citations). Modeling choices with mixed logit handles preference heterogeneity (Devlin et al., 2017). Scalability to 5L versions increases complexity (Feng et al., 2020).

Mapping to Disease Measures

Algorithms map EQ-5D to condition-specific PROs for trials lacking direct EQ-5D data (Fitzpatrick et al., 1998). Regression-based mapping risks bias in QALY estimates (Husereau et al., 2022). Validation against external datasets is needed (Jo, 2014).

Essential Papers

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

Don Husereau, Michael Drummond, Stavros Petrou et al. · 2013 · Value in Health · 2.0K citations

Evaluating patient-based outcome measures for use in clinical trials.

Fitzpatrick, Davey, Buxton et al. · 1998 · Health Technology Assessment · 1.5K citations

T he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologie...

Valuing health-related quality of life: An EQ-5D-5L value set for England

Nancy Devlin, Koonal Shah, Yan Feng et al. · 2017 · Health Economics · 1.3K citations

A new version of the EQ-5D, the EQ-5D-5L, is available. The aim of this study is to produce a value set to support use of EQ-5D-5L data in decision-making. The study design followed an internationa...

Multimorbidity

Søren Thorgaard Skou, Frances S Mair, Martin Fortin et al. · 2022 · Nature Reviews Disease Primers · 1.1K citations

EQ-5D and the EuroQol Group: Past, Present and Future

Nancy Devlin, Richard Brooks · 2017 · Applied Health Economics and Health Policy · 1.1K citations

Over the period 1987-1991 an inter-disciplinary five-country group developed the EuroQol instrument, a five-dimensional three-level generic measure subsequently termed the 'EQ-5D'. It was designed ...

Psychometric properties of the EQ-5D-5L: a systematic review of the literature

You‐Shan Feng, Thomas Kohlmann, Mathieu F. Janssen et al. · 2020 · Quality of Life Research · 822 citations

Self-Reported Population Health: An International Perspective based on EQ-5D

Ágota Szende · 2013 · 758 citations

Biomedicine general; Public Health; Quality of Life Research; Population Health; EQ-5D; Quality-of-Life; Utilities

Reading Guide

Foundational Papers

Start with Husereau et al. (2013, 1975 citations) for CHEERS standards in valuation reporting; Fitzpatrick et al. (1998, 1546 citations) for outcome measure evaluation; Szende (2013, 758 citations) for population health norms.

Recent Advances

Devlin et al. (2017, 1329 citations) for EQ-5D-5L England value set; Feng et al. (2020, 822 citations) for psychometric properties; Husereau et al. (2022, 747 citations) for updated CHEERS.

Core Methods

Time trade-off (TTO) for direct valuation; discrete choice experiments (DCE) with mixed logit modeling (Soekhai et al., 2018); regression mapping to other PROs.

How PapersFlow Helps You Research EQ-5D Utility Valuation

Discover & Search

Research Agent uses searchPapers('EQ-5D value set England DCE') to find Devlin et al. (2017), then citationGraph reveals 1329 citing papers and findSimilarPapers uncovers country-specific sets like Feng et al. (2020). exaSearch queries 'EQ-5D-5L time trade-off validation' for global studies.

Analyze & Verify

Analysis Agent runs readPaperContent on Devlin et al. (2017) to extract DCE modeling details, verifyResponse with CoVe checks utility scores against Szende (2013), and runPythonAnalysis fits mixed logit models from extracted data using pandas/statsmodels. GRADE grading assesses evidence quality for value set recommendations.

Synthesize & Write

Synthesis Agent detects gaps in non-European value sets via contradiction flagging across Devlin (2017) and Szende (2013), while Writing Agent uses latexEditText for valuation manuscripts, latexSyncCitations integrates Husereau (2022), and latexCompile generates camera-ready reports. exportMermaid visualizes DCE preference flows.

Use Cases

"Run regression mapping EQ-5D to SF-6D from trial data"

Research Agent → searchPapers('EQ-5D SF-6D mapping') → Analysis Agent → runPythonAnalysis(ols regression on extracted datasets from Fitzpatrick 1998) → matplotlib utility plot output.

"Draft value set methods section with CHEERS compliance"

Synthesis Agent → gap detection(Husereau 2013/2022) → Writing Agent → latexEditText('methods') → latexSyncCitations(10 papers) → latexCompile → PDF with compliant reporting.

"Find GitHub code for EQ-5D DCE analysis"

Research Agent → searchPapers('EQ-5D discrete choice') → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect Soekhai 2018 supplements) → cloned R/stata scripts for replication.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ EQ-5D valuation papers via searchPapers → citationGraph → GRADE synthesis report on method consistency (Devlin 2017 focus). DeepScan applies 7-step CoVe analysis to verify DCE results from Feng et al. (2020) against population norms. Theorizer generates hypotheses for multimorbidity-adjusted value sets from Skou et al. (2022) + EQ-5D literature.

Try Doxa for EQ-5D Utility Valuation Research

Frequently Asked Questions

What is EQ-5D Utility Valuation?

EQ-5D Utility Valuation elicits preference weights for EQ-5D health states via time trade-off (TTO) or discrete choice experiments (DCE) to compute QALYs (Devlin et al., 2017).

What are main methods in EQ-5D valuation?

TTO asks respondents to trade life years for perfect health; DCE presents choice pairs with duration/severity attributes modeled via logit (Soekhai et al., 2018; Devlin et al., 2017).

What are key papers on EQ-5D valuation?

Devlin et al. (2017, England EQ-5D-5L, 1329 citations); Devlin and Brooks (2017, history, 1110 citations); Szende (2013, population norms, 758 citations).

What are open problems in EQ-5D valuation?

Developing value sets for low/middle-income countries; adjusting for multimorbidity (Skou et al., 2022); improving mapping accuracy to disease-specific measures (Fitzpatrick et al., 1998).